GEN Exclusives

More »

GEN News Highlights

More »
Sep 25, 2007

Potential Biomarkers for Colorectal Adenoma Revealed

  • A team of Chinese researchers report that they have found a particular molecular mechanism underlying adenoma, the precursor lesion of colorectal cancer. “This study found two novel proteins that have never been found to be associated with colorectal cancer,” states Yinghong Wang, the first author of the study.

    The scientists from Zhejiang University, Hangzhou, uncovered 27 differentially expressed proteins using two dimensional electrophoresis and mass spectrometry. Western-blot analysis validated mimecan downregulation and TXNDC5 upregulation in colorectal adenomas and cancers, according to the group.

    “We clearly demonstrated that absence of mimecan and upregulation of TXNDC5 were involved in the early development of colorectal cancer,” according to Wang. “Our further work showed that mimecan can inhibit cell growth and induce cell apoptosis in colorectal cancer cells implying a candidate role as a tumor suppressor gene for the mimecan gene. These results suggested that mimecan might serve as a potential biomarker for future gene therapy.”

    The research article describing this work will appear in the October issue of Experimental Biology and Medicine.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?